M+L)WHY&=?2+_]5O)MAI}}TM620$=,'_P-
SYSTEM PROCESSING...
M+L)WHY&=?2+_]5O)MAI}}TM620$=,'_P-
SYSTEM PROCESSING...
Posted: 2025-08-06 07:45:21 UTC
This article contains some claims that are falsified. While not everything in the article is false, please proceed with extreme caution and verify any critical information independently.
This article contains some claims that are falsified. While not everything in the article is false, please proceed with extreme caution and verify any critical information independently.
Status
Last Updated
2025-08-06 07:45:35 UTC
Verified By
Rollup News
BARDA is terminating 22 mRNA vaccine development investments due to ineffective protection against upper respiratory infections like COVID and flu, and shifting funding to safer, broader vaccine platforms.
Termination of 22 mRNA vaccine development investments
Ineffectiveness against upper respiratory infections
Shift to safer, broader vaccine platforms
mRNA vaccines failing to protect against COVID and flu
Viruses mutating and reducing vaccine effectiveness